Synthesis of Silver-Doxycycline Complex Nanoparticles and Their Biological Evaluation on MCF-7 Cell Line of the Breast Cancer
Author(s) -
Vahid Mohammadkarimi,
Negar Azarpira,
Zahra Ghanbarinasab,
Pezhman Shiri,
Fatemeh Dehghani,
Amin Nakhostin-Ansari,
Fatemeh Tayyebi-Khorrami,
Amir Atapour,
Ali Mohammad Amani
Publication year - 2021
Publication title -
journal of chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.436
H-Index - 50
eISSN - 2090-9063
pISSN - 2090-9071
DOI - 10.1155/2021/9944214
Subject(s) - mcf 7 , chemistry , silver nanoparticle , breast cancer , doxycycline , cancer , cancer cell lines , cell culture , nanoparticle , nanotechnology , cancer research , human breast , cancer cell , medicine , biochemistry , antibiotics , materials science , biology , genetics
In the current study, we aim to evaluate the effect of the combination of silver and doxycycline (silver-doxycycline complex) on the viability of the MCF-7 cell line of the breast in comparison with each of them. The Ag-doxycycline NPs were synthesized using silver nitrate and doxycycline solutions. The synthesized Ag-doxycycline NPs were characterized with several analyses. Ag-doxycycline NPs with a concentration of 25 μM is significantly more effective in decreasing the viability of MCF-7 cells than Ag with the same concentration ( P < 0.05 ). Doxycycline with a concentration of 6.25 μM also has a more potent effect on the viability of MCF-7 cells than Ag with the same concentration ( P < 0.05 ). Ag-doxycycline NPs with a 25 μM concentration is more effective than the concentration of 3.125 μM ( P < 0.05 ). Ag-doxycycline NPs were found to be more effective than AgNPs alone in inhibiting the growth of the MCF-7 cells. Also, the increasing utility of nanotechnology in multiple aspects of medicine can lead to using this technology in the treatment of different types of cancer in the future.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom